Concepedia

Jennifer Adelsperger

JA

7

Publications

4.2K

Citations

7

H-Index

2004

Active since

Affiliations

Howard Hughes Medical Institute(Current)

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Harvard University

Emory University

Jennifer Adelsperger is an author at Howard Hughes Medical Institute specializing in cell biology, medicine, and cancer research.

Top concepts

Publications per year

2004–2007

7

Publications

7

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Ross L. Levine, Martha Wadleigh, Jan Cools et al. · Cancer Cell · 2005 · 3K citations · Full text

, , +11

Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype

Joseph D. Growney, Hirokazu Shigematsu, Zhe Li et al. · Blood · 2005 · 448 citations · Full text

Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412

Joseph D. Growney, Jennifer Clark, Jennifer Adelsperger et al. · Blood · 2005 · 249 citations · Full text

FLT3 Mutations Confer Enhanced Proliferation and Survival Properties to Multipotent Progenitors in a Murine Model of Chronic Myelomonocytic Leukemia

Benjamin H. Lee, Zuzana Tóthová, Ross L. Levine et al. · Cancer Cell · 2007 · 222 citations · Full text

, , +8

PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder

Jing Chen, Daniel J. DeAngelo, Jeffery L. Kutok et al. · Proceedings of the National Academy of Sciences · 2004 · 172 citations · Full text

Rows per page

1–5 of 7